Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 20, 2015
Quintiles announced that Kevin Gordon, currently serving as Executive Vice President, Operations and Chief Financial Officer (CFO), has been promoted to Chief Operating Officer (COO) and that Michael McDonnell is expected to join Quintiles in ...
read more
Tuesday, October 20, 2015
Intertek has formally launched the expanded GLP Bioanalytical Centre of Excellence in San Diego, California, USA to deliver world-class bioanalysis
read more
Tuesday, October 20, 2015
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of two respected industry veterans to its business ...
read more
Tuesday, October 20, 2015
The contract development and manufacturing organisation, Recipharm AB has entered into an agreement whereby it will acquire a majority stake in Nitin Lifesciences Limited, an Indian sterile injectables CMO, currently owned by the Sobti family.
read more
Wednesday, October 14, 2015
Ajinomoto Althea, Inc. today announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs). The new facility is located in close proximity to ...
read more
Wednesday, October 14, 2015
Aesica has unveiled a new approach and business model that solves multiple supply chain challenges at once.
read more
Wednesday, October 14, 2015
Purdue University has announced plans to establish a new Pillars of Excellence in the Life Sciences Initiative aimed at enhancing Purdue’s life sciences research and graduate education. The initiative comes as part of Purdue’s recently announced $2 ...
read more
Wednesday, October 14, 2015
The FDA is alerting health care professionals and patients of a voluntary recall of lots 1 through 67 of non-expired drug products intended to be sterile produced and distributed nationwide by Qualgen LLC, in Edmond, Okla., due to lack of sterility ...
read more
Wednesday, October 14, 2015
Crown Bioscience has entered an exclusive preclinical services alliance utilizing the world’s largest collection of naturally occurring diabetic translational models.
read more
Wednesday, October 14, 2015
Piramal Enterprises' Pharma Solutions division, a global contract development and manufacturing organization (CDMO), has delivered its comprehensive review of the injectables market – both sterile and small molecule – for the next 5 years during its ...
read more
Wednesday, October 14, 2015
Vetter, a global supplier of aseptic manufacturing of drug-delivery systems, has announced the opening of a new business entity in Tokyo, Japan.
read more
Wednesday, October 07, 2015
Envirotainer now launches a new service – an Availability Guarantee that ensures availability of RKN e1 containers at all European locations for all shippers. This unique offering in the market will support the pharmaceutical industry in supplying ...
read more
Tuesday, October 06, 2015
Allele Biotechnology & Pharmaceuticals, a company involved in the development of specialized cells for regenerative medicine and pharmaceutical drug discovery, has announced plans to form a commercial business for the banking of human induced ...
read more
Tuesday, October 06, 2015
AmerisourceBergen has signed a definitive agreement to purchase PharMEDium Healthcare Holdings, Inc., the privately held leading national provider of outsourced compounded sterile prepa.rations (CSPs) to acute care hospitals in the United States, ...
read more
Tuesday, October 06, 2015
Bristol-Myers Squibb has announced that the FDA has accepted for filing and review three supplemental New Drug Applications (sNDAs) for Daklinza(daclatasvir), an NS5A replication complex inhibitor, for use with sofosbuvir with or without ribavirin.
read more